BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37365674)

  • 1. Sensitivity of estimands in clinical trials with imperfect compliance.
    Chen H; Heitjan DF
    Int J Biostat; 2024 May; 20(1):57-67. PubMed ID: 37365674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the Complier Average Causal Effect in a Meta-Analysis of Randomized Clinical Trials With Binary Outcomes Accounting for Noncompliance: A Generalized Linear Latent and Mixed Model Approach.
    Zhou T; Zhou J; Hodges JS; Lin L; Chen Y; Cole SR; Chu H
    Am J Epidemiol; 2022 Jan; 191(1):220-229. PubMed ID: 34564720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bayesian hierarchical model estimating CACE in meta-analysis of randomized clinical trials with noncompliance.
    Zhou J; Hodges JS; Suri MFK; Chu H
    Biometrics; 2019 Sep; 75(3):978-987. PubMed ID: 30690716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A causal model for longitudinal randomised trials with time-dependent non-compliance.
    Becque T; White IR; Haggard M
    Stat Med; 2015 May; 34(12):2019-34. PubMed ID: 25778798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compliance mixture modelling with a zero-effect complier class and missing data.
    Sobel ME; Muthén B
    Biometrics; 2012 Dec; 68(4):1037-45. PubMed ID: 22985224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifiability and estimation of causal effects in randomized trials with noncompliance and completely nonignorable missing data.
    Chen H; Geng Z; Zhou XH
    Biometrics; 2009 Sep; 65(3):675-82. PubMed ID: 18759847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond intent to treat (ITT): A complier average causal effect (CACE) estimation primer.
    Peugh JL; Strotman D; McGrady M; Rausch J; Kashikar-Zuck S
    J Sch Psychol; 2017 Feb; 60():7-24. PubMed ID: 28164801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple imputation methods for treatment noncompliance and nonresponse in randomized clinical trials.
    Taylor L; Zhou XH
    Biometrics; 2009 Mar; 65(1):88-95. PubMed ID: 18397338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Bayesian Hierarchical CACE Model Accounting for Incomplete Noncompliance With Application to a Meta-analysis of Epidural Analgesia on Cesarean Section.
    Zhou J; Hodges JS; Chu H
    J Am Stat Assoc; 2021; 116(536):1700-1712. PubMed ID: 35261417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model misspecification sensitivity analysis in estimating causal effects of interventions with non-compliance.
    Jo B
    Stat Med; 2002 Nov; 21(21):3161-81. PubMed ID: 12375297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the sensitivity of methods for estimating principal causal effects.
    Stuart EA; Jo B
    Stat Methods Med Res; 2015 Dec; 24(6):657-74. PubMed ID: 21971481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regaining power lost by non-compliance via full probability modelling.
    Becque T; White IR
    Stat Med; 2008 Nov; 27(27):5640-63. PubMed ID: 18712776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of treatment efficacy with complier average causal effects (CACE) in a randomized stepped wedge trial.
    Gruber JS; Arnold BF; Reygadas F; Hubbard AE; Colford JM
    Am J Epidemiol; 2014 May; 179(9):1134-42. PubMed ID: 24705812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral support intervention for uncontrolled hypertension: a complier average causal effect (CACE) analysis.
    Liang Y; Ehler BR; Hollenbeak CS; Turner BJ
    Med Care; 2015 Feb; 53(2):e9-e15. PubMed ID: 23269112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing complier average causal effects from longitudinal trials with multiple endpoints and treatment noncompliance: An application to a study of Arthritis Health Journal.
    Guo L; Qian Y; Xie H
    Stat Med; 2022 Jun; 41(13):2448-2465. PubMed ID: 35274333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An extended general location model for causal inferences from data subject to noncompliance and missing values.
    Peng Y; Little RJ; Raghunathan TE
    Biometrics; 2004 Sep; 60(3):598-607. PubMed ID: 15339281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Complier Average Causal Effect Parameter for Multiarmed RCTs.
    Schochet PZ
    Eval Rev; 2020 Oct; 44(5-6):410-436. PubMed ID: 33375826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating causal effects of treatment in RCTs with provider and subject noncompliance.
    Sheng E; Li W; Zhou XH
    Stat Med; 2019 Feb; 38(5):738-750. PubMed ID: 30347462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The specific effect of systematic exposure in irritable bowel syndrome: complier average causal effect analysis using growth mixture modeling.
    Hesser H; Hedman E; Lindfors P; Andersson E; Ljótsson B
    Psychol Med; 2017 Nov; 47(15):2653-2662. PubMed ID: 28464975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating Causal Effects in Trials Involving Multi-Treatment Arms Subject to Non-compliance: A Bayesian framework.
    Long Q; Little RJ; Lin X
    J R Stat Soc Ser C Appl Stat; 2010 May; 59(3):513-531. PubMed ID: 21637737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.